CBDV isolate for specialist cannabinoid development.

CBD-V from Cilo Cybin's GMP cannabinoid API portfolio: ≥98% CBDV specification target, off-white to yellow crystalline powder, and formulation-ready documentation.

This page provides supporting information about Cilo Cybin's company platform, products, services, and stakeholder communications.

A CBDV isolate option for licensed development teams building differentiated cannabinoid formulations.

CBD-V, or cannabidivarin, is a rare non-intoxicating cannabinoid input for development teams building differentiated cannabinoid products. Cilo Cybin positions CBD-V as an off-white to yellow crystalline powder with a ≥98% CBDV specification target and a ≤0.01% THC target.

CBD-V is relevant where the product concept requires a defined rare cannabinoid with low sensory impact and precise dosing. Development programs often evaluate CBD-V for capsules, soft gels, oils, gummies, topical systems, skincare, and specialist wellness formats. For broader CBD-led programs, buyers can compare CBD Isolate , CBD Distillate 85% , and CBD CRD .

Use these pages to move between adjacent products without losing the family context.

Send the Cilo Cybin team your target format, desired specification, estimated volume, destination market, and documentation requirements.

Pharmaceutical biotechnology for regulated cannabinoid API's, bulk products, finished formats, and partner supply programs.

For partnership, product, or company enquiries, contact Cilo Cybin for the latest approved information.